 Purdue and the three executives admitted that Purdue fraudulently marketed OxyContin by falsely claiming that OxyContin was less addictive, less subject to abuse, and less likely to cause withdrawal symptoms than other pain medications when there was no medical research to support these claims and without Food and Drug Administration approval of these claims.The company and executives paid over $634 million in fines, and the executives were placed on 3 years probation and ordered to perform 400 hours of community service.While the settlement was one of the largest financial penalties ever imposed on a drug company, under pressure from Purdue lawyer Rudy Giuliani Brownlee agreed to modify the prosecution so that Purdue Pharma's holding company, Purdue Frederick, would plead to a single misbranding charge so that Purdue Pharma would not have a criminal conviction on their name, which would prevent them from doing business with the U.S. Government.